Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Test results

19 May 2009 08:00

RNS Number : 4559S
Plant Health Care PLC
19 May 2009
 



19 May 2009

Plant Health Care plc 

("Plant Health Care" or "the Company")

The Journal of the American Society of Horticultural Science recently published the findings of an extensive testing and research progamme carried out on Plant Health Care's harpin product when used with lettuce (J. AMER. SOC. HORT. SCI. 134(1):141-147. 2009.). 

A summary of the findings is set out below.


 

 

Researchers from three US academic institutions (Rutgers University, University of California, Davis and University of Arizona), led by Dr. Jorge M. Fonseca at the University of Arizona's Yuma Agricultural Center, have investigated the effect of a pre-harvest treatment of head lettuce with Plant Health Care's harpin protein which is known to boost plants' growth processes and resistance to disease.

Lettuce plants grown at the three locations were treated, five days before harvest with three different rates of the harpin A/B second generation protein. After processing and bagging the lettuces were cool-stored and their quality evaluated over a period of 20 days.

At the two higher rates, the harpin-treated lettuce from California consistently showed better visual quality and lower microbial population than the control. Similarly in Arizona, for part of the storage period, microbial population was lower and visual quality was higher in lettuce treated with harpin at the two higher rates. Overall results in New Jersey showed no major differences among treatments. 

In additional experiments it was shown that antioxidants increased by 40% in head leaves when plants were treated with the two higher rates of harpin, but no visible changes were observed in outer leaves. Furthermore, phenolic content was higher in all treated lettuce than in the control lettuce after 24 hours. Six days later, the levels fell back to the initial stage. 

Overall, it was shown that a pre-harvest, field application of harpin can improve quality of fresh-cut head lettuce under certain environmental conditions. The results with antioxidant activity and phenolic content suggest that improvement in quality is probably the result of alteration of metabolites' composition.

The study clearly shows the potential for harpin use as a pre-harvest treatment to improve several important health and appearance-related aspects of this important produce crop.

- ends -

Enquiries:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Evolution Securities

Tavistock Communications 

Tim Worlledge / Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300 

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk

About Plant Health Care plc:

Plant Health Care plc is a leading provider of natural products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, Plant Health Care currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company listed on the AIM market of the London Stock Exchange in July 2004. Ticker symbol is PHC.

Plant Health Care's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAKSPFLLNEFE
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.